TUESDAY, June 6, 2023 (HealthDay News) -- Few patients diagnosed with cancer between 2013 and 2019 in California and Georgia underwent germline testing, according to a study published online…
– Toripalimab plus chemotherapy resulted in a 37% reduction in the risk of death, HR=0.63, versus chemotherapy alone, in nasopharyngeal carcinoma patients – – No treatments are approved…